Overview of restless legs syndrome

Hospital Medicine

Volumn 62, Issue 8, 2001, Pages 487-489

  Amar, Khaled ^a  

^a ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; IRON;

DIFFERENTIAL DIAGNOSIS; HUMAN; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; REVIEW;

ANTI-ANXIETY AGENTS; BENZODIAZEPINES; DIAGNOSIS, DIFFERENTIAL; DOPAMINE AGENTS; HUMANS; IRON; POLYSOMNOGRAPHY; QUALITY OF LIFE; RESTLESS LEGS SYNDROME;

EID: 0035434112     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2001.62.8.1625     Document Type: Article

References (21)

1. Allen RP, Barker PB, Wehrl F et al (2001 ) MR! measurement of brain iron in patients with restless legs syndrome. Neurology 56: 263-5
2. Benes H, Kurella B, Kummer J et al (1999) Rapid onset of action of levodopa in restless legs syndrome: a doubleblind, randomised, multicentre, cross over trial. Sleep 22: 1073-81
3. Boghen D (1981) Successful treatment of restless legs syndrome with clonazepam. Ann Neurol 8: 341
4. Davis BJ, Rajpit A, Rajput ML et al (2000) A randomised double-blind placebo-controlled trial of iron in restless legs syndrome. Eur Neurol 43: 70-75
5. Earley CJ, Connors JR. Allen RP (1999) RLS patients have abnormally reduced CSF ferritin compared to normal controls. Neurology 52 (suppl 2): AI 11-A112
6. Ekbom KA (1945) Restless legs : a clinical study. Ada Met/ iVW 158 (suppl): 4-122
7. Lauerma H. Markkula J (1999) Treatment of restless legs syndrome with tramadol: an open study. J Clin Psvchiatry 60:241
8. Lazzarini A, Walters AS. Hickey K et al (1999) Studies of penetrance and anticipation in five autosomal dominant restless legs syndrome pedigrees. Mov Disurd 14: 111-16
9. Mellick G. Mellick L ( 1995) Successful treatment of restless legs syndrome with gabapentin. .Vw/jv 45 (suppl 4): 285-6
10. Michaud M. Chabli A, Lavigne Ci, Montplaisir J (2000) Arm restlessness in patients with restless legs syndrome. Mov Disord 15: 289-93
11. Montplaisir J, Lorrain D. Godbout R (1991) Restless legs syndrome and periodic leg movement of sleep: the primary role of dopaminergic mechanism. Eur Neurol 31: 41-3
12. Montplaisir J, Boucher S, Poirier G et al (1997) Clinical, polysomnographic and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disonl 12: 61-5
13. Montplaisir J, Nicolas A. Denesle R et al (1999) Restless legs syndrome improved by pramipexole: a double blind randomised trial. Neumlogv 52: 938-t3
14. Phillips B, Young T. Finn L'et al (2000) Epidemiology of restless legs symptoms in adults. Arch Intern Med 160: 2137-41
15. Polydefkis M. Alien RP, Hauer P et al (2000) Subclinical sensory neuropathy in late onset restless legs syndrome. ,Vf itmlogv 55: 1115-21
16. Rothdach AJ. Trenkwalder C, Haberstock J et al (2000) Prevalence and risk factors of RLS in an elderly population - the MEMO study. Neumlogv 54: 1064-8
17. Routtinen HM, Partinen M, Hublin C et al (2000) An FDOPA PET study in patients with periodic leg movement disorder and restless legs syndrome. Neumlogv 54: 502-1
18. Stiasny K, Robbecke .I. Schuler P et al (2000) treatment of idiopathic restless legs syndrome (RLS) with the dopamine agonist cabergoline - an open clinical trial. Sleep 23: 349-54
19. Sun ER, Chen ER, Ho G et al (1998) Iron and the restless legs syndrome. Sleep 21: 371-7
20. Trenkwalder C, Walters AS, Hening WA et al ( 1999) Positron emission tomography studies in restless legs syndrome. Mov Disord 14: 141-5
21. Walters AS and International RLS Study Group (1995) Towards a better definition of the restless leg syndrome. Movement Dis 10: 634 -42